Oruka Therapeutics (ORKA) Net Cash Flow Growth (5y) (2015 - 2026)
Oruka Therapeutics (ORKA) Net Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - |
| 4 | BeOne Medicines | 470.64 Bn | 465.84 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.91 Bn | 115.67 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.77 Bn | 62.77 Bn | - |
| 8 | Argenx Se | 56.21 Bn | 51.02 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.60 Bn | 37.60 Bn | - |
| 10 | Oruka Therapeutics | 953.82 Mn | 122.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.06% |
| Dec 31, 2025 | -85.40% |
| Sep 30, 2025 | -8.37% |
| Jun 30, 2025 | -77.25% |
| Mar 31, 2025 | 71.93% |
| Dec 31, 2024 | -206.95% |
| Sep 30, 2024 | 315.78% |
| Jun 30, 2024 | -53.20% |
| Mar 31, 2024 | 81.77% |
| Dec 31, 2023 | 6.12% |
| Sep 30, 2023 | -1.11% |
| Jun 30, 2023 | 22.37% |
| Mar 31, 2023 | -19.82% |
| Dec 31, 2022 | -36.09% |
| Sep 30, 2022 | -21.10% |
| Jun 30, 2022 | -23.68% |
| Mar 31, 2022 | -28.42% |
| Dec 31, 2021 | -48.16% |
| Sep 30, 2021 | 4.92% |
| Jun 30, 2021 | 24.61% |